Literature DB >> 921442

Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis?

H Gavras, I Gavras, P J Cannon, H R Brunner, J H Laragh.   

Abstract

The pathologic lesions of the kidney in scleroderma in many respects resemble those of malignant hypertension, perhaps even in the absence of comparable blood pressure elevation. Because the malignant vascular changes have been related to hyperreninemia, we measured plasma renin activity in 23 patients with scleroderma with or without hypertension and/or renal failure. We found that high renin levels in most cases shortly preceded or coincided with a phase of sudden deterioration of the disease, characterized by a rapidly progressive renal failure. The outcome of this phase was invariably fatal, except for two patients in whom bilateral nephrectomy successfully arrested the rapid downhill course. These findings suggest that an unexplained increase in circulating renin levels in an otherwise stable patient with scleroderma may be taken as a possible marker of imminent deterioration requiring close monitoring and immediate therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 921442

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

1.  Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement.

Authors:  R Livi; L Teghini; A Pignone; S Generini; M Matucci-Cerinic; M Cagnoni
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

2.  Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril.

Authors:  B Waeber; M D Schaller; J P Wauters; H R Brunner
Journal:  Klin Wochenschr       Date:  1984-08-01

3.  A controlled trial of antihypertensive therapy in systemic sclerosis (scleroderma).

Authors:  J F Fries; C Wasner; J Brown; P Feigenbaum
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

Review 4.  A "silent" course of normotensive scleroderma renal crisis: case report and review of the literature.

Authors:  Hadim Akoglu; Gokhan Kadir Atilgan; Ramazan Ozturk; Ezgi Coskun Yenigun; Ipek Isik Gonul; Ali Riza Odabas
Journal:  Rheumatol Int       Date:  2008-12-02       Impact factor: 2.631

5.  Failure of captopril to reverse the renal crisis of scleroderma.

Authors:  E A Brown; G A Macgregor; R N Maini
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

6.  Scleroderma renal crisis.

Authors:  L Michael Prisant; Don H Loebl; Laura L Mulloy
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Mar-Apr       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.